skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Studies remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Measuring US Pharmaceutical Industry R&D Spending
Measuring US Pharmaceutical Industry R&D Spending
Material Type:
Artigo 		Adicionar ao Meu Espaço

Measuring US Pharmaceutical Industry R&D Spending

Golec, Joseph ; Vernon, John

PharmacoEconomics, 2008-01, Vol.26 (12), p.1005-1017 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
2
An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis
An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis

Jenkins, R Gisli ; Moore, Bethany B ; Chambers, Rachel C ; Eickelberg, Oliver ; Königshoff, Melanie ; Kolb, Martin ; Laurent, Geoffrey J ; Nanthakumar, Carmel B ; Olman, Mitchell A ; Pardo, Annie ; Selman, Moises ; Sheppard, Dean ; Sime, Patricia J ; Tager, Andrew M ; Tatler, Amanda L ; Thannickal, Victor J ; White, Eric S

American journal of respiratory cell and molecular biology, 2017-05, Vol.56 (5), p.667-679 [Periódico revisado por pares]

United States: American Thoracic Society

Texto completo disponível

Citações Citado por
3
Innovation in the pharmaceutical industry: New estimates of R&D costs
Innovation in the pharmaceutical industry: New estimates of R&D costs
Material Type:
Artigo 		Adicionar ao Meu Espaço

Innovation in the pharmaceutical industry: New estimates of R&D costs

DiMasi, Joseph A. ; Grabowski, Henry G. ; Hansen, Ronald W.

Journal of health economics, 2016-05, Vol.47, p.20-33 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
4
The 8th International Congress on Cutaneous Adverse Drug Reactions, Taiwan, 2013: Focus on Severe Cutaneous Adverse Reactions
The 8th International Congress on Cutaneous Adverse Drug Reactions, Taiwan, 2013: Focus on Severe Cutaneous Adverse Reactions
Material Type:
Artigo 		Adicionar ao Meu Espaço

The 8th International Congress on Cutaneous Adverse Drug Reactions, Taiwan, 2013: Focus on Severe Cutaneous Adverse Reactions

Dodiuk-Gad, Roni P. ; Chung, Wen-Hung ; Yang, Chih-Hsun ; Lu, Chun-Wei ; Hui, Rosaline Chung-Yee ; Shear, Neil H.

Drug safety, 2014-06, Vol.37 (6), p.459-464 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
5
Congress should clarify the circumstances under which drug makers can communicate results on comparative effectiveness
Congress should clarify the circumstances under which drug makers can communicate results on comparative effectiveness
Material Type:
Artigo 		Adicionar ao Meu Espaço

Congress should clarify the circumstances under which drug makers can communicate results on comparative effectiveness

Klasmeier, Coleen

Health Affairs, 2012-10, Vol.31 (10), p.2220-2224 [Periódico revisado por pares]

United States: The People to People Health Foundation, Inc., Project HOPE

Texto completo disponível

Citações Citado por
6
Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research Consortium
Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research Consortium
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research Consortium

Sager, Philip T., MD ; Seltzer, Jonathan, MD ; Turner, J. Rick, PhD ; Anderson, Jeffrey L., MD ; Hiatt, William R., MD ; Kowey, Peter, MD ; Prochaska, Judith J., PhD, MPH ; Stockbridge, Norman, MD, PhD ; White, William B., MD

The American heart journal, 2015-04, Vol.169 (4), p.486-495 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
7
Pharmaceutical Policy In China
Pharmaceutical Policy In China
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmaceutical Policy In China

Sun, Qiang ; Santoro, Michael A ; Meng, Qingyue ; Liu, Caitlin ; Eggleston, Karen

Health Affairs, 2008-07, Vol.27 (4), p.1042-1050 [Periódico revisado por pares]

United States: Health Affairs

Texto completo disponível

Citações Citado por
8
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
Material Type:
Artigo 		Adicionar ao Meu Espaço

Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus

Nation, Roger L, Prof ; Li, Jian, Prof ; Cars, Otto, Prof ; Couet, William, Prof ; Dudley, Michael N, Pharm D ; Kaye, Keith S, Prof ; Mouton, Johan W, Prof ; Paterson, David L, Prof ; Tam, Vincent H, Prof ; Theuretzbacher, Ursula, PhD ; Tsuji, Brian T, Pharm D ; Turnidge, John D, Prof

The Lancet infectious diseases, 2015-02, Vol.15 (2), p.225-234 [Periódico revisado por pares]

United States: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
The impact of public basic research on industrial innovation: Evidence from the pharmaceutical industry
The impact of public basic research on industrial innovation: Evidence from the pharmaceutical industry
Material Type:
Artigo 		Adicionar ao Meu Espaço

The impact of public basic research on industrial innovation: Evidence from the pharmaceutical industry

Toole, Andrew A.

Research policy, 2012-02, Vol.41 (1), p.1-12 [Periódico revisado por pares]

Amsterdam: Elsevier B.V

Texto completo disponível

Citações Citado por
10
Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012
Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012

Vilhelmsson, Andreas ; Davis, Courtney ; Mulinari, Shai Lexchin, Joel

PLoS medicine, 2016-01, Vol.13 (1), p.e1001945-e1001945 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (3.245)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (3.610)
  2. magazinearticle  (81)
  3. Artigos de Jornal  (45)
  4. Newsletter Articles  (27)
  5. Resenhas  (12)
  6. Anais de Congresso  (8)
  7. Mais opções open sub menu

Idioma 

  1. Inglês  (3.765)
  2. Japonês  (260)
  3. Português  (30)
  4. Espanhol  (10)
  5. Alemão  (8)
  6. Francês  (4)
  7. Turco  (2)
  8. Húngaro  (1)
  9. Árabe  (1)
  10. Esloveno  (1)
  11. Serbian  (1)
  12. Africâner  (1)
  13. Tcheco  (1)
  14. Croatian  (1)
  15. Lituano  (1)
  16. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.